Nuvectis Pharma, Inc. (NVCT) NASDAQ
9.51
-0.24(-2.46%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
9.51
-0.24(-2.46%)
Currency In USD
| Market Cap | 164.69M |
| Enterprise Value | 133.05M |
| P/E Ratio | -8.2 |
| PEG Ratio | 0.46 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 15.66 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -8.04 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.07 |
| Return On Equity | -1.48 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -27.57M |
| Net Income | -26.44M |
| Diluted EPS | -1.32 |
| Total Cash | 25.13M |
| Total Cash/Share | 1.07 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.27 |
| Book Value Per Share | 0.61 |
| 52-Week Change | 5.9 |
| 52-Week High | 13.34 |
| 52-Week Low | 5.55 |
| Moving Average 50 Days | 9.16 |
| Moving Average 200 Days | 7.72 |
| Average Volume | 79,211 |
| Shares Outstanding | 26.53M |
| % Held by Institutions | 20.72 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |